Cite
Long-term molecular efficacy and safety of imatinib in a patient with chronic myeloid leukaemia after renal transplantation.
MLA
Antoine Thierry, et al. “Long-Term Molecular Efficacy and Safety of Imatinib in a Patient with Chronic Myeloid Leukaemia after Renal Transplantation.” Nephrology Dialysis Transplantation, vol. 22, no. 6, May 2007, p. 1791. EBSCOhost, https://doi.org/10.1093/ndt/gfm052.
APA
Antoine Thierry, Brigitte Dreyfus, Frank Bridoux, Ramzi Abou Ayache, Serge Milin, François Guilhot, & Guy Touchard. (2007). Long-term molecular efficacy and safety of imatinib in a patient with chronic myeloid leukaemia after renal transplantation. Nephrology Dialysis Transplantation, 22(6), 1791. https://doi.org/10.1093/ndt/gfm052
Chicago
Antoine Thierry, Brigitte Dreyfus, Frank Bridoux, Ramzi Abou Ayache, Serge Milin, François Guilhot, and Guy Touchard. 2007. “Long-Term Molecular Efficacy and Safety of Imatinib in a Patient with Chronic Myeloid Leukaemia after Renal Transplantation.” Nephrology Dialysis Transplantation 22 (6): 1791. doi:10.1093/ndt/gfm052.